US2008318313A1PendingUtilityA1

Method to Prevent Graft Rejection Using TGF-Beta to Induce T Suppressor Cells

Assignee: UNIV SOUTHERN CALIFORNIAPriority: Apr 11, 2000Filed: Oct 30, 2007Published: Dec 25, 2008
Est. expiryApr 11, 2020(expired)· nominal 20-yr term from priority
A61K 39/001A61P 37/06A61K 2035/124C12N 2501/15A61K 2035/122A61K 40/4229A61K 40/418A61K 40/22A61K 40/11C12N 5/0636
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to compositions and methods useful for preventing graft rejection in a recipient following organ transplantation.

Claims

exact text as granted — not AI-modified
1 . One or more suppressor T cells capable of decreasing graft rejection of a solid organ by a recipient made by the process comprising:
 a) isolating peripheral blood mononuclear cells (PBMC) from a recipient and an organ donor;   b) irradiating T cell-depleted mononuclear cells from said organ donor PBMC; and   c) combining ex vivo said recipient PBMC with said donor irradiated T cell-depleted mononuclear cells and a regulatory composition comprising TGF-β to induce one or more recipient suppressor T cells.   
   
   
       2 . A population of suppressor T cells capable of decreasing graft rejection of a solid organ by a recipient made by the process comprising:
 a) isolating peripheral blood mononuclear cells (PBMC) from a recipient and an organ donor;   b) irradiating T cell-depleted mononuclear cells from said organ donor PBMC;   c) combining ex vivo said recipient PBMC with said donor irradiated T cell-depleted mononuclear cells and a regulatory composition comprising TGF-β to induce a PBMC population comprising one or more recipient suppressor T cells; and   d) wherein a recipient suppressor T cell population is produced by expanding said recipient suppressor T cells.   
   
   
       3 . The suppressor T cells according to  claim 1  or  2 , wherein said regulatory composition further comprises cytokines selected from the group consisting of IL-2 and IL-15. 
   
   
       4 . The suppressor T cells according to  claim 1  or  2 , wherein said PBMC from said recipient are enriched for CD4+ T cells. 
   
   
       5 . The suppressor T cells according to  claim 4 , wherein said CD4+ cells are enriched for naive CD4+ T cells. 
   
   
       6 . The suppressor T cells according to  claim 1  or  2 , wherein said PBMC from said recipient are enriched for CD8+ T cells.

Join the waitlist — get patent alerts

Track US2008318313A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.